Why the Incannex (ASX:IHL) share price is soaring 13%

The Incannex share price is soaring today as the company mulls a US listing. We take a closer look at its release.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Incannex Healthcare Ltd (ASX: IHL) share price is soaring today as the company announced that it is mulling a US listing. Shares in the small-cap health care stock are currently trading 12.82% higher as a result. This has held Incannex shares to rise to a price of 22 cents.

Why is the Incannex share price flying?

Today the Incannex share price is trading strongly higher. This comes as the company announced that it is intending to list on the US market. The company has executed a binding consulting agreement with EAS Advisors to facilitate the listing.

Incannex noted that the predominant purpose of the arrangement was for EAS to introduce it to US banks and institutions. With the aim of dual listing the company on either the Nasdaq Composite (INDEXNASDAQ: .IXIC) or the NYSE Composite (INDEXNYSEGIS: NYA). While also retaining its listing on the ASX.

It is worth noting that the term of the agreement is 12 months. EAS will be paid both with Incannex options and a standard retainer. The advisory firm is also going to assist with financial modelling, presentation preparation, and external data room maintenance. This will be on top of generating global investor awareness.

Management Comments

CEO and Managing Director of Incannex Healthcare, Joel Latham, welcomed the news by saying:

After several months of getting to know one another, Eddie and EAS have joined our broader team to evaluate opportunities to list IHL securities in the United States on one of the main markets. We have made this decision because of deep investor interest and corporate activity in both cannabinoid-based pharmaceuticals and psychedelic therapeutic endeavours in North America. We're delighted to be working with the team at EAS, which has an excellent track record of growing international awareness for ASX companies.

About the Incannex share price

The Incannex share price has performed well as of late as it recently released positive drug results.

In the last month alone, its shares are up a whopping 37.5%, easily outpacing the All Ordinaries Index (ASX: XAO). Incannex is currently valued at $229.24 million.

Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Woman with an amazed expression has her hands and arms out with a laptop in front of her.
Share Gainers

Why BlueScope, DroneShield, Monadelphous, and SGH shares are racing higher today

These shares are outperforming on Tuesday. But why?

Read more »

Multiple ASX share investors take on one another in a tug of war in a high rise building.
Mergers & Acquisitions

BlueScope shares jump 20% on takeover news

This steel company is a takeover target. Here's what you need to know.

Read more »

A group of executives sit in front of computer screens in a darkened room while a colleague stands giving a presentation with a share price graphic lit up on the wall
Share Market News

IAG integrates RACQ Insurance into reinsurance

IAG brings RACQ Insurance into its core reinsurance program, expanding coverage and seeking greater resilience against natural catastrophe risks.

Read more »

Two company members shaking hands on a deal.
Share Market News

Monadelphous awarded $175 million BHP contract: Key details for investors

Monadelphous Group shares are in focus after landing a major $175 million construction contract with BHP in Western Australia.

Read more »

two business men sit across from each other at a negotiating table. with a large window in the background.
Share Market News

SGH confirms $13.2 billion acquisition offer for BlueScope Steel

SGH confirms a $13.2 billion joint offer to acquire BlueScope Steel, with plans for strategic business separation.

Read more »

A person leans over to whisper a secret to a colleague during a meeting.
Share Market News

BlueScope fields $30-per-share takeover bid from SGH, Steel Dynamics

The company previously rejected several earlier bids.

Read more »

woman working on tablet
Opinions

2 incredible ASX 200 shares I'd buy with $2,000 right now

These stocks are some of the best that Australians can buy.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Dividend Investing

2 ASX dividend shares with yields above 7%!

These stocks offer investors significant potential income.

Read more »